BALB-p53Neu male mice, injected to generate IGF2-dependent rhabdomyosarcoma, were treated with anti-IGFs antibodies and the results indicated a significant delay in the sarcoma onset and prolonged overall survival [186]. Here, IGF2 is linked to rhabdomyosarcoma.